About
Mr. Arnold serial entrepreneur of medical device and life sciences companies who advises life science inventors and entrepreneurs on strategy and is active in company formation and financing. From 2001 to 2005 he was CEO of CardioFocus where he developed a unique endoscopic catheter for treating atrial fibrillation - now in human trials. Prior to that he founded Cambridge Heart, Inc. (NASDAQ: CAMH), a supplier of cardiology diagnostic equipment, which he took public in 1996. Prior to that he was CEO of Molecular Simulations, Inc., a $100 MM supplier of software for drug design now called Accelrys (NASDAQ: ACCL). In his early career Mr. Arnold held senior R&D and marketing positions for Becton Dickinson and ran the instrumentation group for medical equipment supplier Datascope Corp. Mr. Arnold is a guest lecturer at the MIT Entrepreneurship Center and Sloan School, a mentor to early stage companies through the MIT Venture Mentoring Society and is on the grant review board at the MIT D
Position in the VCSift Database
- • 2 investors at Boston Harbor Angels are tracked.
- • 57 investors hold the Member role in VCSift. Jeffrey Arnold is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
Find more investors like Jeffrey
Search Investors